Company Quratis Inc.

A348080

KR7348080003

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Share class

Shareholders

Company contact information

Sector

Sector Other Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-06-10 EDT			5-day change	1st Jan Change
1,149 ^KRW	-3.93%		-7.26%	-47.41%

2023	Quratis Inc. announced that it has received KRW 7.99999791 billion in funding from LINFRA Corp	CI
2023	Quratis Inc. announced that it expects to receive KRW 7.99999791 billion in funding	CI

Quratis Inc is a Korea-based company primarily engaged in the manufacture and sale of biopharmaceuticals. The Company is engaged in the manufacture and sale of vaccine, peptide nucleic acid complex. The Company is also engaged in the provision of Cell Penetrating Peptide (CPP) platform services. In addition, the Company is engaged in the development and research of vaccines, such as tuberculosis vaccines for adults and adolescents, and COVID-19 vaccines.

KRW in Million	2022	Weight	2023	Weight	Delta
Drug Development 100.0 %	8,409	100.0 %	1,030	100.0 %	-87.75%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 100.0 %	8,409	100.0 %	1,030	100.0 %	-87.75%

Managers	Title	Age	Since
Kwan-Gu Cho CEO	Chief Executive Officer	-	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	42,152,010	31,146,099 ( 73.89 %)	0	73.89 %
Stock B	0	213,612	0	0

Name	Equities	%	Valuation
Kwan-Gu Cho 6.555 %	2,763,220	6.555 %	3 M ₩
Linfra Corp. 5.632 %	2,373,887	5.632 %	2 M ₩
Kiwoom-Yollim Healthcare Investment Association No 1 5.590 %	2,356,468	5.590 %	2 M ₩
SJ Investment Partners Co., Ltd. 4.598 %	1,938,082	4.598 %	2 M ₩
Kclavis Investment Co. Ltd. 3.660 %	1,542,857	3.660 %	1 M ₩
Korea Asset Investment Securities Co. Ltd. /Venture Capital/ 2.834 %	1,194,516	2.834 %	1 M ₩
Asset One 2.425 %	1,022,239	2.425 %	985 653 ₩
Eun-Ju Lee 1.898 %	800,000	1.898 %	771 368 ₩
Yonsei Medical Clinic 1.139 %	480,000	1.139 %	462 821 ₩
ORION HOLDINGS CORP. 0.9885 %	416,666	0.9885 %	401 754 ₩

Quratis, Inc.

9th Floor, Daeryeong Seocho Tower 327 Gangnam-daero

06627, Seoul

http://www.quratis.com

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
QURATIS INC.	-47.41%	36.68M
ELI LILLY AND COMPANY	+48.53%	779B
NOVO NORDISK A/S	+40.67%	631B
JOHNSON & JOHNSON	-6.37%	354B
MERCK & CO., INC.	+20.93%	333B
ABBVIE INC.	+8.21%	301B
ASTRAZENECA PLC	+16.75%	249B
ROCHE HOLDING AG	-1.19%	216B
NOVARTIS AG	+10.85%	214B
AMGEN INC.	+4.40%	163B

Other Pharmaceuticals